Mark J Rosenblum - Net Worth and Insider Trading
Mark J Rosenblum Net Worth
The estimated net worth of Mark J Rosenblum is at least $1,236 dollars as of 2024-12-27. Mark J Rosenblum is the Exec VP Finance, CFO of Salarius Pharmaceuticals Inc and owns about 742 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $1,234. Mark J Rosenblum is also the CFO of Advaxis Inc and owns about 2 shares of Advaxis Inc (ADXS) stock worth over $2. Details can be seen in Mark J Rosenblum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J Rosenblum has not made any transactions after 2022-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark J Rosenblum
Mark J Rosenblum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J Rosenblum owns 3 companies in total, including Salarius Pharmaceuticals Inc (SLRX) , ActiveCare Inc (ACARQ) , and Advaxis Inc (ADXS) .
Click here to see the complete history of Mark J Rosenblum’s form 4 insider trades.
Insider Ownership Summary of Mark J Rosenblum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-05-31 | Exec VP Finance & Interim CFO |
| ACARQ | ActiveCare Inc | 2017-12-11 | director & Chief Executive Officer |
| ADXS | Advaxis Inc | 2013-10-24 | Chief Financial Officer |
Mark J Rosenblum Latest Holdings Summary
Mark J Rosenblum currently owns a total of 2 stocks. Among these stocks, Mark J Rosenblum owns 742 shares of Salarius Pharmaceuticals Inc (SLRX) as of May 31, 2022, with a value of $1,234 and a weighting of 99.85%. Mark J Rosenblum also owns 2 shares of Advaxis Inc (ADXS) as of October 24, 2013, with a value of $2 and a weighting of 0.15%.
Latest Holdings of Mark J Rosenblum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-05-31 | 742 | 1.66 | 1,234 |
| ADXS | Advaxis Inc | 2013-10-24 | 2 | 0.95 | 2 |
Holding Weightings of Mark J Rosenblum
Mark J Rosenblum Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J Rosenblum has made a total of 5 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 140 shares on May 31, 2022, which cost Mark J Rosenblum around $5,040.
According to the SEC Form 4 filings, Mark J Rosenblum has made a total of 0 transactions in Advaxis Inc (ADXS) over the past 5 years. The most-recent trade in Advaxis Inc is the acquisition of 10 shares on October 24, 2013, which cost Mark J Rosenblum around $48,000.
Insider Trading History of Mark J Rosenblum
- 1
Mark J Rosenblum Trading Performance
GuruFocus tracks the stock performance after each of Mark J Rosenblum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Rosenblum is -1.22%. GuruFocus also compares Mark J Rosenblum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Rosenblum within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark J Rosenblum's insider trading performs compared to the benchmark.
Performance of Mark J Rosenblum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.19 | | | | | |
| Relative Return to S&P 500(%) | 2.05 | | | | | |
Mark J Rosenblum Ownership Network
Mark J Rosenblum Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Mark J Rosenblum is the Exec VP Finance & Interim CFO of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include director & Chief Executive Officer David J. Arthur , Chief Financial Officer Scott Jordan , and Controller Pao-yu Chuang .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Mark J Rosenblum Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J Rosenblum. You might contact Mark J Rosenblum via mailing address: 3990 Spring Valley Road, Apt. 1218, Dallas Tx 75244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
